The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.